Journal article
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
H Calkins, KH Kuck, R Cappato, J Brugada, A John Camm, SA Chen, HJG Crijns, RJ Damiano, DW Davies, J DiMarco, J Edgerton, K Ellenbogen, MD Ezekowitz, DE Haines, M Haissaguerre, G Hindricks, Y Iesaka, W Jackman, J Jalife, P Jais Show all
Journal of Interventional Cardiac Electrophysiology | SPRINGER | Published : 2012
Abstract
This is a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation, developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology and the European Cardiac Arrhythmia Society (ECAS), and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). This is endorsed by the governing bodies of the ACC Foundation, the AHA, the ECAS, the EHRA, the STS, the APHRS, and the HRS. © Springer Science+Business Media, LLC 2011.
Grants
Funding Acknowledgements
Research Grant St. Jude Medical (b), Biotronik (b), Sorin (b), Boston Scientific, (b), Medtronic (b), Medtronic (d), Boston Scientific (d), St. Jude Medical (d), Sanofi Aventis (e), Daiichi Sankyo (f), BMS (e), Pfizer (e), Servier (e), Johnson & Johnsonm(e), Boston Scientific (c), Biosense Webster (c), Sorin Group (c), Bard (c), St. Jude Medical (c), St Jude Medical (e), Merck (f), Sanofi Aventis (e), Boehringer Ingelheim (f), Boston Scientific (f), None Atricure (c), Medtronic (e), None Atricure (c), Medtronic (d), Boston Scientific (d), St. Jude Medical (b), Biosense Webster (d), None St. Jude Medical (b), Medtronic (b), Toray Medical (b), None Biosense Webster (c), Biotronik (d), St. Jude Medical (f), None None None None Medtronic (e), None St. Jude Medical (d), 3M Medica/MEDA Pharma (d), Cardovascular Therapeutics (d), Medtronic (d), OMRON (d), Sanofi aventis (d), St. Jude Medical (d), BMBF (d), Fondation Leducq (d), German Research Foundation (d), DFG (d), European Union (d), None None Biosense Webster (b), CryoCath Technologies, Inc. (b), Stereotaxis (b), Medtronic (b), St. Jude Medical (b), Cordis Webster - Johnson & Johnson (b), Edwards Lifesciences (b), None None Biosense Webster (d), St Jude Medical (d), Rhythmia (d), MC10 (c), Voyage Medical (c) Biosense Webster (b), St. Jude Medical (b), None St. Jude Medical (d), Boston Scientific (d), Sanofi Aventis (d), Biosense Webster (d), Medtronic (d), None Biosense Webster (a), Biosense Webster (e), St. Jude Medical (d), Stereotaxis (d), Rhythmia Medical (d), Endosense SA (d), None AstraZeneca (f), NIH (f), Medtronic (f), Thermedical (d), EpiEP (c), St. Jude Medical (f), Minnesota Partnership for Biotechnology and Medical Genomic / University of Minnesota (f), Biosense Webster (f), Biotronik (e), None None St. Jude Medical (b), Biosense Webster (b), Endosense (b), Medtronic (b), CardioFocus (b), Atritech (b), Phillips (b), Voyage Medical (b) SentreHeart (b), None None None None